Estrogen-progestins and progestins for the management of endometriosis

Paolo Vercellini; Laura Buggio; Nicola Berlanda; Giussy Barbara; Giussy Barbàra; Edgardo Somigliana; Silvano Bosari; Silvano Bòsari

doi:10.1016/j.fertnstert.2016.10.022

Estrogen-progestins and progestins for the management of endometriosis

Paolo Vercellini, Laura Buggio, Nicola Berlanda, Giussy Barbara, Giussy Barbàra, Edgardo Somigliana, Silvano Bosari, Silvano Bòsari

Fertility and sterility · 2016 · vol. 106(7) , pp. 1552–1571.e2 · doi:10.1016/j.fertnstert.2016.10.022 · PMID:27817837 · W2548119897

review OA: closed CC0 ⤵ 164 in-corpus citations

Limited metadata. Only one source feed has indexed this record so far — no abstract, full text, or open-access copy is available through Endo Lab. The publisher's page (linked below) is the canonical location for the actual content. If you have institutional access, use "Find at my library".

View at publisher → View on OpenAlex View on PubMed

⚙ AI-generated summary by claude@2026-06, 2026-06-07 ⓘ

This paper reviews the use of estrogen-progestins and progestins in managing endometriosis, outlining their mechanisms and clinical applications.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

My notes (saved in your browser only)

Condition tags

endometriosis

MeSH descriptors

Endometriosis Endometrium Estrogens Progestins Endometriosis Endometriosis Endometriosis Endometriosis Endometrium Endometrium Endometrium Endometrium Estrogens Estrogens Female Humans Patient Selection Progestins Progestins Risk Assessment

Citation neighborhood

Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.

References (100)

Cited by (50)

Source provenance

europepmc: last seen: 2026-06-11T06:19:48.454388+00:00
openalex: last seen: 2026-06-10T17:14:06.276822+00:00
pubmed: last seen: 2026-05-13T22:20:43.714878+00:00

License: CC0 · commercial use OK

[1] A call for more transparency of registered clinical trials on endometriosis via openalex

[2] A comparison of progestogens or oral contraceptives and gonadotropin-releasing hormone agonists for the treatment of endometriosis: a systematic review via openalex

[3] A gonadotropin-releasing hormone agonist versus a continuous oral contraceptive pill in the treatment of bladder endometriosis via openalex

[4] A gonadotropin-releasing hormone agonist versus a low-dose oral contraceptive for pelvic pain associated with endometriosis via openalex

[5] A levonorgestrel-releasing intrauterine system for the treatment of dysmenorrhea associated with endometriosis: a pilot study via openalex

[6] Anatomical distribution of deeply infiltrating endometriosis: surgical implications and proposition for a classification via openalex

[7] Association of History of Surgery for Endometriosis With Severity of Deeply Infiltrating Endometriosis via openalex

[8] BLADDER ENDOMETRIOSIS: CONSERVATIVE MANAGEMENT via openalex

[9] Blood biomarkers for the non-invasive diagnosis of endometriosis via openalex

[10] ‘Blood On The Tracks’ from corpora lutea to endometriomas* via openalex

[11] Can symptomatology help in the diagnosis of endometriosis? Findings from a national case–control study—Part 1 via openalex

[12] Changes in the size of rectovaginal endometriotic nodules infiltrating the rectum during hormonal therapies via openalex

[13] Clinical Management of Endometriosis via openalex

[14] Clinical Management of Endometriosis via openalex

[15] Combination of the non-invasive tests for the diagnosis of endometriosis via openalex

[16] Comparison of a levonorgestrel-releasing intrauterine device versus expectant management after conservative surgery for symptomatic endometriosis: a pilot study via openalex

[17] Complications after surgery for deeply infiltrating pelvic endometriosis via openalex

[18] Complications, pregnancy and recurrence in a prospective series of 500 patients operated on by the shaving technique for deep rectovaginal endometriotic nodules via openalex

[19] Continuous low‐dose oral contraceptive in the treatment of colorectal endometriosis evaluated by rectal endoscopic ultrasonography via openalex

[20] Continuous use of an oral contraceptive for endometriosis-associated recurrent dysmenorrhea that does not respond to a cyclic pill regimen via openalex

[21] Continuous use of oral contraceptives: an overview of effects and side‐effects via openalex

[22] Continuous versus cyclic oral contraceptives after laparoscopic excision of ovarian endometriomas: a systematic review and metaanalysis via openalex

[23] Continuous versus cyclic oral contraceptives for the treatment of endometriosis: a systematic review via openalex

[24] Cyproterone acetate versus a continuous monophasic oral contraceptive in the treatment of recurrent pelvic pain after conservative surgery for symptomatic endometriosis via openalex

[25] Dienogest compared with gonadotropin‐releasing hormone agonist after conservative surgery for endometriosis via openalex

[26] Dienogest in women with persistent endometriosis-related pelvic pain during norethisterone acetate treatment via openalex

[27] Dienogest is as effective as intranasal buserelin acetate for the relief of pain symptoms associated with endometriosis—a randomized, double-blind, multicenter, controlled trial via openalex

[28] Dienogest is as effective as triptorelin in the treatment of endometriosis after laparoscopic surgery: results of a prospective, multicenter, randomized study via openalex

[29] Effect of progestogens and combined oral contraceptives on nerve fibers in peritoneal endometriosis via openalex

[30] Effects of the levonorgestrel-releasing intrauterine system on cardiovascular risk markers in patients with endometriosis: a comparative study with the GnRH analogue via openalex

[31] Elagolix, an Oral GnRH Antagonist, Versus Subcutaneous Depot Medroxyprogesterone Acetate for the Treatment of Endometriosis: Effects on Bone Mineral Density via openalex

[32] Endometriosis via openalex

[33] Endometriosis and ovarian cancer: potential benefits and harms of screening and risk-reducing surgery via openalex

[34] Endometriosis and risks for ovarian, endometrial and breast cancers: A nationwide cohort study via openalex

[35] Endometriosis-associated nerve fibers, peritoneal fluid cytokine concentrations, and pain in endometriotic lesions from different locations via openalex

[36] Endometriosis: Diagnosis and Management via openalex

[37] Endometriosis: epidemiology and aetiological factors via openalex

[38] Endometriosis: hormone regulation and clinical consequences of chemotaxis and apoptosis via openalex

[39] Endometriosis: pathogenesis and treatment via openalex

[40] Endometriosis: the effects of dienogest via openalex

[41] Endometriosis: the effects of dienogest. via openalex

[42] Endometriosis: the elusive gray area between evidence-based and evidence-biased medicine via openalex

[43] ESHRE guideline for the diagnosis and treatment of endometriosis via openalex

[44] Estrogen and progesterone receptors in smooth muscle component of deep infiltrating endometriosis via openalex

[45] Feasibility and Safety of Laparoscopic-Assisted Bowel Segmental Resection for Deep Infiltrating Endometriosis: A Retrospective Cohort Study With Description of Technique via openalex

[46] Gonadotrophin‐releasing hormone analogue or dienogest plus estradiol valerate to prevent pain recurrence after laparoscopic surgery for endometriosis: a multi‐center randomized trial via openalex

[47] Hormonal therapy for endometriosis: from molecular research to bedside via openalex

[48] Impact of Medical and Surgical Treatment of Endometriosis on the Cure of Endometriosis and Pain via openalex

[49] Introduction via openalex

[50] Is rectovaginal endometriosis a progressive disease? via openalex

[51] Lack of Transparency of Clinical Trials on Endometriosis via openalex

[52] Laparoscopic Colorectal Resection for Bowel Endometriosis via openalex

[53] Levonorgestrel‐releasing intrauterine system (Mirena <sup>®</sup> ) and Depot medroxyprogesterone acetate (Depoprovera) as long‐term maintenance therapy for patients with moderate and severe endometriosis: A randomised controlled trial via openalex

[54] Long‐term adjuvant therapy for the prevention of postoperative endometrioma recurrence: a systematic review and meta‐analysis via openalex

[55] Long-Term Administration of Dienogest Reduces Recurrence after Excision of Endometrioma via openalex

[56] Long-term cyclic and continuous oral contraceptive therapy and endometrioma recurrence: a randomized controlled trial via openalex

[57] Long-term oral contraceptive pills and postoperative pain management after laparoscopic excision of ovarian endometrioma: a randomized controlled trial via openalex

[58] Low-dose oral contraceptive pill for dysmenorrhea associated with endometriosis: a placebo-controlled, double-blind, randomized trial via openalex

[59] Maintenance therapy involving a tapering dose of danazol or mid/low doses of oral contraceptive after gonadotropin-releasing hormone agonist treatment for endometriosis-associated pelvic pain via openalex

[60] Medical treatment for rectovaginal endometriosis: what is the evidence? via openalex

[61] Molecular Biology of Endometriosis: From Aromatase to Genomic Abnormalities via openalex

[62] Molecular Mechanisms of Treatment Resistance in Endometriosis: The Role of Progesterone–Hox Gene Interactions via openalex

[63] New trends of progestins treatment of endometriosis via openalex

[64] Non-invasive diagnosis of endometriosis: the goal or own goal? via openalex

[65] Norethindrone acetate or dienogest for the treatment of symptomatic endometriosis: a before and after study via openalex

[66] Norethisterone acetate in the treatment of colorectal endometriosis: a pilot study via openalex

[67] On-label and off-label drug use in the treatment of endometriosis via openalex

[68] Oral contraceptives and risk of endometriosis: a systematic review and meta-analysis via openalex

[69] Oral contraceptives in the prevention of endometrioma recurrence: does the different progestins used make a difference? via openalex

[70] Oral contraceptive use, reproductive history, and risk of epithelial ovarian cancer in women with and without endometriosis via openalex

[71] Origins and Progression of Adolescent Endometriosis via openalex

[72] Ovarian endometrioma—Risks factors of ovarian cancer development via openalex

[73] Oxidative stress in the pelvic cavity and its role in the pathogenesis of endometriosis via openalex

[74] Pathogenesis and pathophysiology of endometriosis via openalex

[75] Pelvic Endometriosis Diagnosed in an Entire Nation Over 20 Years via openalex

[76] Peritoneal endometriosis, ovarian endometriosis, and adenomyotic nodules of the rectovaginal septum are three different entities via openalex

[77] Postoperative administration of dienogest plus estradiol valerate versus levonorgestrel‐releasing intrauterine device for prevention of pain relapse and disease recurrence in endometriosis patients via openalex

[78] Post-operative cyclic oral contraceptive use after gonadotrophin-releasing hormone agonist treatment effectively prevents endometrioma recurrence via openalex

[79] Postoperative hormonal therapy after surgical excision of deep endometriosis via openalex

[80] Postoperative Levonorgestrel-Releasing Intrauterine System for Pelvic Endometriosis-Related Pain via openalex

[81] Postoperative Medical Therapy After Surgical Treatment of Endometriosis: From Adjuvant Therapy to Tertiary Prevention via openalex

[82] Postoperative oral contraceptive exposure and risk of endometrioma recurrence via openalex

[83] Post-operative oral contraceptive use reduces the risk of ovarian endometrioma recurrence after laparoscopic excision via openalex

[84] Post-operative use of oral contraceptive pills for prevention of anatomical relapse or symptom-recurrence after conservative surgery for endometriosis via openalex

[85] Practice Bulletin No. 114: Management of Endometriosis via openalex

[86] Pre and post-operative medical therapy for endometriosis surgery via openalex

[87] Prevention of the recurrence of symptom and lesions after conservative surgery for endometriosis via openalex

[88] Priorities for Endometriosis Research: A Proposed Focus on Deep Dyspareunia via openalex

[89] Progestagens and anti-progestagens for pain associated with endometriosis via openalex

[90] Progestins for symptomatic endometriosis: a critical analysis of the evidence via openalex

[91] Progestin Therapy in Endometriosis via openalex

[92] Progestogens for endometriosis: forward to the past via openalex

[93] Recurrence of ovarian endometrioma after laparoscopic excision: Risk factors and prevention via openalex

[94] Reducing low-value care in endometriosis between limited evidence and unresolved issues: a proposal via openalex

[95] Reproductive performance in infertile women with rectovaginal endometriosis: Is surgery worthwhile? via openalex

[96] Rich innervation of deep infiltrating endometriosis via openalex

[97] Safety of medical treatments for endometriosis via openalex

[98] Sexual function in endometriosis patients and their partners: effect of the disease and consequences of treatment via openalex

[99] Subcutaneous depot medroxyprogesterone acetate versus leuprolide acetate in the treatment of endometriosis-associated pain via openalex

[100] Subcutaneous injection of depot medroxyprogesterone acetate compared with leuprolide acetate in the treatment of endometriosis-associated pain via openalex